Prevalence of malaria parasitemia among patients attending Uke General Hospital, Karu Local Government Area, Nasarawa State, Nigeria.

Authors

  • Dr. Igba, P Ave Maria University PIYANKO, Nasarawa State Author
  • Prof. Ehinmidu, J.O. Translator
  • Salisu Rukayyat Author
  • Dr. Hassan, S.C. Translator

DOI:

https://doi.org/10.66811/68w78t07

Keywords:

Malaria, Plasmodium falciparum, Protist, Public health, Nigeria

Abstract

Malaria persists as major public health concern in Nigeria. Malaria, an infectious disease spread by mosquitoes, is caused by plasmodium protist. Nigeria accounts for 27% of the global malaria burden and 32% of malaria deaths globally (FRN, 2022). Malaria poses a risk of about 97% to the Nigerian population and contributes about 11% of maternal mortality. This study sought to establish the prevalence of malaria parasitemia among patients attending Uke General Hospital, Karu Local Government Area, Nasarawa State, Nigeria. the study was structured around three key objectives: To determine the malaria prevention practices among the patients visiting the hospital, to identify some socio-cultural factors that can be included in the education of people for effective control programme and to compare the prevalence of malaria parasite infection caused by plasmodium falciparum among patients attending Uke General Hospital Karu Local Government Nasarawa State. A quantitative research design was adopted, Using rapid diagnostic tests (RDT) kits, 120 patients of different ages and genders were screened for malaria. Analysis of collected Capillary blood samples showed that 65 individuals were positive, giving prevalence rate of 54.2%. Children aged 1-10years showed the highest prevalence, and males were generally more affected than females. Although light microscopy is regarded as the gold standard for malaria diagnosis, RDTs were used in this study due to their speed, ease of use, and availability in the hospital setting. These findings demonstrate the ongoing burden of malaria in the study area and the need to reinforce prevention and control strategies. There should be intensive public awareness campaigns on malaria transmission, symptoms, prevention, and the importance of seeking timely treatment. These campaigns should be targeted especially at the uneducated population through the use of local languages and visual aids.

Downloads

Download data is not yet available.

Author Biographies

  • Dr. Igba, P, Ave Maria University PIYANKO, Nasarawa State

    Department of Microbiology, Ave Maria University Piyanko, FCT, Abuja (Doctor)

  • Prof. Ehinmidu, J.O.

    Department of pharmaceutical Microbiology, A.B.U. Zaria (Processor)

  • Salisu Rukayyat

    Department of Microbiology, Ave Maria University Piyanko, FCT Abuja. 

  • Dr. Hassan, S.C.

    Department of Zoology, Nasarawa State University Keffi. Nigeria (Doctor)

References

Adetunji, B. O., Olorunfemi, E. O., Olufemi, T. J., and Adeoye, P. O. (2024). The

impact of insecticide-treated bed nets on malaria prevention in rural

Nigerian communities. African Journal of Infectious Diseases, 18(2),

112–122.

Adikwu, E. A., Omokhoa, A. O., and Bello, M. T. (2024). Prevalence and sociodemographic determinants of malaria in urban Nigeria. Journal of Tropical

Diseases and Public Health, 12(1), 45–55.

Band, G., Rockett, K., Spencer, C., and others. (2022). Genetic Factors and Host

Immunity in Malaria Susceptibility. Malaria Journal, 21(10), 1-13.

Belay, D., Tadesse, A., and Gebre, Y. (2021). Species distribution of Plasmodium

parasites: A systematic review. Parasitology Research Review, 16(3), 215–

230.

Bello, M. K., Usman, A. A., Yusuf, T. A., and Salisu, H. S. (2022). Age and gender

variations in malaria prevalence among outpatients attending health centers in

Northern Nigeria. Nigerian Journal of Parasitology, 43(1), 77–86.

Bloland, P. B. (2001). Drug Resistance in Malaria. World Health Organization.

Centers for Disease Control and Prevention (CDC). (2006). Malaria Life Cycle.

https://www.cdc.gov

Centers for Disease Control and Prevention (CDC). (2014). Malaria Factsheet.

https://www.cdc.gov

Centers for Disease Control and Prevention (CDC). (2024). Malaria - Epidemiology

and Transmission. https://www.cdc.gov

Centre for Disease Control and Prevention. (2020). The economic burden of malaria in

Nigeria. CDC Nigeria Reports.

Centre for Disease Control and Prevention. (2022). Malaria case and mortality

estimates – 2021. Global Malaria Program.

Centre for Disease Control and Prevention. (2023). Diagnostic accuracy and malaria

treatment practices. CDC Diagnostic Reviews.

Chua, C. L. L., and others. (2021). The Impact of Malaria During Pregnancy. Lancet

Infectious Diseases, 21(2), 167-178.

Chukwu, O. O., Oduwole, A. O., Adebayo, O. A., and Okonkwo, U. P. (2021). The

influence of education level on malaria prevention practices in Sub-Saharan

Africa: Evidence from Nigeria. Malaria Research and Treatment, 2021,

Article ID 6689710.

De Lima, P. G., and others. (2025). Blood-Brain Barrier Disruption in Cerebral Malaria.

Frontiers in Neurology, 16(1), 1-11.

Diagne, N., and others. (2024). Impact of Mixed Malaria Infections. Parasites and

Vectors, 17(2), 14-20.

Ebadan, M.I., Basil, N.O., Amiegheme, F.E., and Aiyeki, G.E. (2017). Prevalenc and

susceptibility of Malaria parasites infection in association with blood

group and haemoglobin genotype polymorphism in pregnancy.

International Journal of Communities Research; 6(2): 2-8

Eze, C. J., Okafor, J. O., Nwosu, P. C., and Uzochukwu, B. S. (2022). Healthcareseeking behavior and malaria outcomes among rural populations in

Southeast Nigeria. Journal of Public Health in Africa, 13(3), 235–244.

Felix, C. O., Onah, P. I., Okechukwu, O. E., and Umeh, C. C. (2024). Prevalence and

risk factors of malaria among patients in a semi-urban hospital in Nigeria.

International Journal of Malaria Control, 10(1), 34–42.

Felix, O. A., Johnson, F. M., and Peter, U. (2024). Global malaria risk: epidemiology

and policy challenges. International Health Journal, 19(2), 125–138.

Federal Republic of Nigeria. (2022). National malaria elimination strategy 2021–2025.

Abuja: Federal Ministry of Health.

Funmilola, S. A1., Bernard, U.L1, Ifeanyi, F.O2., Maureen, N.O1 And Mary, U.O1

(2022). Malaria Prevalence And Haematological Status Of

Individuals Inlafiagyibadegi Community, Katcha Local Government Area,

Niger, Nigeria. Journal Of Science, Technology, Mathematics And

Education;18(3)

Gallego-Delgado, J., and others. (2023). Malaria Pathogenesis and Immunopathology.

Current Opinion in Hematology, 30(2), 82-90.

Garba, H. A., and others. (2024). Prevalence of Mixed Malaria Infections in Niger.

Tropical Medicine and Health, 52(4), 411-420.

Gebreegziabher, T., and others. (2023). Malnutrition and Malaria Severity in Children.

BMC Infectious Diseases, 23(1), 1012-1020.

Glineur, S., and others. (2022). Cytokines and Cerebral Malaria Pathology. Journal of

Infectious Diseases, 225(3), 469-478.

Global Burden of Disease Collaborative Network (2025). Global Burden of Disease

Study 2025 (GBD 2025) Results for Malaria. Seattle, United States: Institute

for Health Metrics and Evaluation (IHME).

https://www.healthdata.org/gbd/2025

Global Burden of Disease (GBD). (2025). Global Burden of Disease Study 2025:

Malaria. Institute for Health Metrics and Evaluation (IHME).

Ibrahim, M. J., Chukwu, O. A., and Okeke, C. C. (2023). Economic impact of malaria

on African households. African Journal of Health Economics, 5(2), 75–86.

Ibrahim, S. M., Garba, A. A., and Yusuf, S. L. (2022). Prevalence and control of

Plasmodium species in Nigeria: A regional study. Malaria Journal of Africa,

8(4), 210–222.

Isiko, R., and others. (2024). Age Factors in Malaria Transmission. BMJ Global Health,

9(1), 113-122.

Malaria Consortium. (2024). Nigeria: Malaria Burden Report.

Mokuola, O. B. (2025). Local production and distribution of dual-insecticide nets in

Kaduna State. Nigerian Journal of Public Health, 10(1), 50–60.

Ngum, P. N., Afolayan, J. O., and Nkeze, G. (2023). Climatic and socio-demographic

influences on malaria prevalence in sub-Saharan Africa. Environmental

Health Perspectives, 131(4), 670–678.

Nigeria Malaria Indicator Survey. (2012). Malaria Prevalence in Nigeria.

Njila, F. L., Onyango, J. O., and Achieng, M. M. (2022). Diagnostics for antimalarial

efficacy: cost and implementation challenges in Africa. Journal of

Tropical Medicine, 14(2), 90– 102.

Oboh, I., and others. (2020). Mixed Species Infections in Nigeria. Malaria Journal,

19(112), 19.

Ogunyemi, A. A., and Adeyemi, K. S. (2023). Gender disparities in malaria exposure

and treatment-seeking behaviors in Southwestern Nigeria. Nigerian Journal

of Tropical Medicine, 23(1), 67–75.

Oladele, B. I., Yusuf, T. R., and Eze, C. (2018). Malaria’s impact on children’s

education and development in Nigeria. Child Health and Development Review,

6(2), 30–38.

Omoya, J. E., Adeoye, B. A., and Ojo, T. F. (2020). Socio-demographic factors

associated with malaria admissions in Nigerian hospitals. Journal of

Infectious Diseases in Developing Countries, 14(9), 420–428.

Onwujekwe, O., and others. (2013). Economic Impact of Malaria on Households in

Nigeria. Malaria Journal, 12(1), 307.

Oyerogba, A. T., Sunday, I. O., and Ayodeji, S. F. (2023). Over‐prescription of

antimalarials: A case study from Lagos clinics. African Health Sciences,

23(1), 112–119.

PAN (Partnership for African Health). (2024). Malaria outpatient and admissions data

report – Nigeria. PAN Health Organization.

Piccaluga, P., and Ignatius, K. (2023). Endothelial Dysfunction in Severe Malaria.

Microvascular Research, 146(4), 104510.

Simpson, J. A., and others. (2002). Modeling Malaria Parasite Dynamics. Parasitology,

124, 247- 259.

Sultana, R., Sharma, K., and Das, S. (2017). Light microscopy in malaria diagnosis:

technique and limitations. Clinical Parasitology Today, 11(3), 140–147.

Tinashe, P., Chibale, K., and Moyo, S. (2018). Vector control interventions: targeting

pregnant women and children. African Vector-Borne Disease Journal,

4(1), 12–20.

Ugochukwu, E. F., and others. (2010). Regional Variations in Malaria Prevalence in

Nigeria. Nigerian Journal of Pediatrics, 37(3), 120-126.

Ujuju, C. I., Nwafor, C. C., and Okonkwo, E. J. (2023). Malaria parasitemia in children

aged 6 to 24 months in southeastern Nigeria. Pediatric Parasitology

Journal, 9(2), 88–95.

Umar, M. A., Lawal, Y. M., Ibrahim, A. A., and Garba, M. B. (2020). Comparative

analysis of herbal remedies and conventional treatment of malaria in

Northern Nigeria. Nigerian Journal of Pharmaceutical Sciences, 19(2), 190–

199.

Umaru, A. M., Danjuma, U. M., and Aliyu, A. B. (2015). Knowledge and practices

regarding malaria diagnosis in northern Nigeria. Nigerian Journal of

Medicine, 24(3), 160–166.

White, N. J., and others. (2014). Plasmodium Life Cycle and Drug Resistance. Lancet

Infectious Diseases, 14(7), 581-594.

World Health Organization (WHO). (2015). World Malaria Report 2015.

World Health Organization (WHO). (2020). World Malaria Report 2020.

World Health Organization (WHO). (2024). World Malaria Report 2024.

World Health Organization. (2020). World malaria report 2020. Geneva: WHO.

World Health Organization. (2021). Malaria: Key Facts. Geneva: WHO.

World Health Organization. (2022). Guidelines for Malaria. Geneva: WHO.

World Health Organization. (2022). World malaria report 2022. Geneva: WHO.

World Health Organization. (2023). WHO recommendation on dual-insecticide

mosquito nets. Geneva: WHO.

World Health Organization. (2023). World malaria report 2023. Geneva: WHO.

World Health Organization. (2024). Updated Recommendations on Malaria Diagnosis

and Treatment. Geneva: WHO.

Downloads

Published

2026-05-29

How to Cite

Prevalence of malaria parasitemia among patients attending Uke General Hospital, Karu Local Government Area, Nasarawa State, Nigeria. (2026). EIJRIHS, 1(2), 1-29. https://doi.org/10.66811/68w78t07

Similar Articles

1-10 of 18

You may also start an advanced similarity search for this article.